426 related articles for article (PubMed ID: 25457535)
1. Characterization of renal cell carcinoma, oncocytoma, and lipid-poor angiomyolipoma by unenhanced, nephrographic, and delayed phase contrast-enhanced computed tomography.
Ishigami K; Pakalniskis MG; Leite LV; Lee DK; Holanda DG; Rajput M
Clin Imaging; 2015; 39(1):76-84. PubMed ID: 25457535
[TBL] [Abstract][Full Text] [Related]
2. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
[TBL] [Abstract][Full Text] [Related]
3. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
[TBL] [Abstract][Full Text] [Related]
4. Subtype Differentiation of Small (≤ 4 cm) Solid Renal Mass Using Volumetric Histogram Analysis of DWI at 3-T MRI.
Li A; Xing W; Li H; Hu Y; Hu D; Li Z; Kamel IR
AJR Am J Roentgenol; 2018 Sep; 211(3):614-623. PubMed ID: 29812980
[TBL] [Abstract][Full Text] [Related]
5. Small renal masses (≤ 4 cm): differentiation of oncocytoma from renal clear cell carcinoma using ratio of lesion to cortex attenuation and aorta-lesion attenuation difference (ALAD) on contrast-enhanced CT.
Gentili F; Bronico I; Maestroni U; Ziglioli F; Silini EM; Buti S; de Filippo M
Radiol Med; 2020 Dec; 125(12):1280-1287. PubMed ID: 32385827
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of rapid kV-switching dual energy CT in renal tumor characterization.
Çamlıdağ İ; Nural MS; Danacı M; Özden E
Abdom Radiol (NY); 2019 May; 44(5):1841-1849. PubMed ID: 30637472
[TBL] [Abstract][Full Text] [Related]
7. Sarcomatoid Renal Cell Carcinoma and Collecting Duct Carcinoma: Discrimination From Common Renal Cell Carcinoma Subtypes and Benign RCC Mimics on Multiphasic MDCT.
Young JR; Young JA; Margolis DJA; Sauk S; Sayre J; Pantuck AJ; Raman SS
Acad Radiol; 2017 Oct; 24(10):1226-1232. PubMed ID: 28528853
[TBL] [Abstract][Full Text] [Related]
8. Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma.
Pierorazio PM; Hyams ES; Tsai S; Feng Z; Trock BJ; Mullins JK; Johnson PT; Fishman EK; Allaf ME
Urology; 2013 Jun; 81(6):1265-71. PubMed ID: 23601445
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of clear from non-clear cell renal cell carcinoma using CT washout formula.
Kopp RP; Aganovic L; Palazzi KL; Cassidy FH; Sakamoto K; Derweesh IH
Can J Urol; 2013 Jun; 20(3):6790-7. PubMed ID: 23783049
[TBL] [Abstract][Full Text] [Related]
10. Small (< 4 cm) Renal Mass: Differentiation of Oncocytoma From Renal Cell Carcinoma on Biphasic Contrast-Enhanced CT.
Sasaguri K; Takahashi N; Gomez-Cardona D; Leng S; Schmit GD; Carter RE; Leibovich BC; Kawashima A
AJR Am J Roentgenol; 2015 Nov; 205(5):999-1007. PubMed ID: 26496547
[TBL] [Abstract][Full Text] [Related]
11. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of Clear Cell Renal Cell Carcinoma From Other Subtypes and Fat-Poor Angiomyolipoma by Use of Quantitative Enhancement Measurement During Three-Phase MDCT.
Kim SH; Kim CS; Kim MJ; Cho JY; Cho SH
AJR Am J Roentgenol; 2016 Jan; 206(1):W21-8. PubMed ID: 26700359
[TBL] [Abstract][Full Text] [Related]
13. Are there useful CT features to differentiate renal cell carcinoma from lipid-poor renal angiomyolipoma?
Yang CW; Shen SH; Chang YH; Chung HJ; Wang JH; Lin AT; Chen KK
AJR Am J Roentgenol; 2013 Nov; 201(5):1017-28. PubMed ID: 24147472
[TBL] [Abstract][Full Text] [Related]
14. Histogram analysis of small solid renal masses: differentiating minimal fat angiomyolipoma from renal cell carcinoma.
Chaudhry HS; Davenport MS; Nieman CM; Ho LM; Neville AM
AJR Am J Roentgenol; 2012 Feb; 198(2):377-83. PubMed ID: 22268181
[TBL] [Abstract][Full Text] [Related]
15. Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT.
Kim JK; Park SY; Shon JH; Cho KS
Radiology; 2004 Mar; 230(3):677-84. PubMed ID: 14990834
[TBL] [Abstract][Full Text] [Related]
16. Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses.
Lee-Felker SA; Felker ER; Tan N; Margolis DJ; Young JR; Sayre J; Raman SS
AJR Am J Roentgenol; 2014 Nov; 203(5):W516-24. PubMed ID: 25341166
[TBL] [Abstract][Full Text] [Related]
17. Circularity Index on Contrast-Enhanced Computed Tomography Helps Distinguish Fat-Poor Angiomyolipoma from Renal Cell Carcinoma: Retrospective Analyses of Histologically Proven 257 Small Renal Tumors Less Than 4 cm.
Kang HS; Park JJ
Korean J Radiol; 2021 May; 22(5):735-741. PubMed ID: 33660463
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of CT texture analysis in differentiating benign and malignant renal tumours.
Deng Y; Soule E; Cui E; Samuel A; Shah S; Lall C; Sundaram C; Sandrasegaran K
Clin Radiol; 2020 Feb; 75(2):108-115. PubMed ID: 31668402
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of multidetector computed tomography to differentiate between renal cell carcinoma and oncocytoma. A model validation.
Paño B; Soler A; Goldman DA; Salvador R; Buñesch L; Sebastià C; Nicolau C
Br J Radiol; 2020 Nov; 93(1115):20200064. PubMed ID: 32706993
[TBL] [Abstract][Full Text] [Related]
20. Use of Iodine Concentration in the Lipid-Poor Portion of the Renal Mass for Differentiation of Angiomyolipoma from Renal Cell Carcinoma.
Sun J; Zhang XY; Li XT; Li YL; Wang ZL
Cancer Biother Radiopharm; 2019 May; 34(4):224-230. PubMed ID: 31070481
[No Abstract] [Full Text] [Related]
[Next] [New Search]
